Clinical Trials Browser

Phase 1/2 × Neoplasms × isatuximab × Clear all

NCT03637764 2023-07-10

Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies

Phase 1/2 Terminated

107 enrolled 30 charts

Neoplasms